annual CFF:
-$34.20M-$25.63M(-299.05%)Summary
- As of today (July 7, 2025), MDXG annual cash flow from financing activities is -$34.20 million, with the most recent change of -$25.63 million (-299.05%) on December 31, 2024.
- During the last 3 years, MDXG annual CFF has fallen by -$30.85 million (-920.26%).
- MDXG annual CFF is now -154.41% below its all-time high of $62.86 million, reached on December 31, 2019.
Performance
MDXG Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$2.88M-$2.48M(-619.50%)Summary
- As of today (July 7, 2025), MDXG quarterly cash flow from financing activities is -$2.88 million, with the most recent change of -$2.48 million (-619.50%) on March 31, 2025.
- Over the past year, MDXG quarterly CFF has increased by +$30.59 million (+91.40%).
- MDXG quarterly CFF is now -104.31% below its all-time high of $66.75 million, reached on June 30, 2019.
Performance
MDXG quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$3.61M+$30.59M(+89.44%)Summary
- As of today (July 7, 2025), MDXG TTM cash flow from financing activities is -$3.61 million, with the most recent change of +$30.59 million (+89.44%) on March 31, 2025.
- Over the past year, MDXG TTM CFF has increased by +$38.42 million (+91.41%).
- MDXG TTM CFF is now -105.54% below its all-time high of $65.19 million, reached on June 30, 2019.
Performance
MDXG TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MDXG Cash from financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -299.1% | +91.4% | +91.4% |
3 y3 years | -920.3% | -177.8% | -73.6% |
5 y5 years | -154.4% | -32.2% | +46.7% |
MDXG Cash from financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -5796.4% | at low | -877.8% | +91.4% | -898.7% | +91.5% |
5 y | 5-year | -154.4% | at low | -104.3% | +91.4% | -105.8% | +91.5% |
alltime | all time | -154.4% | +43.4% | -104.3% | +91.4% | -105.5% | +94.0% |
MDXG Cash from financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$2.88M(+619.5%) | -$3.61M(-89.4%) |
Dec 2024 | -$34.20M(+299.1%) | -$400.00K(-1581.5%) | -$34.20M(-20.0%) |
Sep 2024 | - | $27.00K(-107.5%) | -$42.74M(+0.8%) |
Jun 2024 | - | -$359.00K(-98.9%) | -$42.40M(+0.9%) |
Mar 2024 | - | -$33.47M(+274.4%) | -$42.03M(+390.5%) |
Dec 2023 | -$8.57M(+1377.6%) | -$8.94M(-2516.2%) | -$8.57M(-2065.6%) |
Sep 2023 | - | $370.00K(+9150.0%) | $436.00K(+122.4%) |
Jun 2023 | - | $4000.00(-200.0%) | $196.00K(-56.6%) |
Mar 2023 | - | -$4000.00(-106.1%) | $452.00K(-177.9%) |
Dec 2022 | -$580.00K(-82.7%) | $66.00K(-49.2%) | -$580.00K(-7.1%) |
Sep 2022 | - | $130.00K(-50.0%) | -$624.00K(-31.0%) |
Jun 2022 | - | $260.00K(-125.1%) | -$904.00K(-56.5%) |
Mar 2022 | - | -$1.04M(-4809.1%) | -$2.08M(-37.9%) |
Dec 2021 | -$3.35M(-105.4%) | $22.00K(-114.7%) | -$3.35M(-27.4%) |
Sep 2021 | - | -$150.00K(-83.6%) | -$4.62M(-107.4%) |
Jun 2021 | - | -$916.00K(-60.3%) | $62.27M(+1.4%) |
Mar 2021 | - | -$2.31M(+85.7%) | $61.43M(-0.2%) |
Dec 2020 | $61.56M(-2.1%) | -$1.24M(-101.9%) | $61.56M(-0.2%) |
Sep 2020 | - | $66.73M(-3906.8%) | $61.67M(-1010.2%) |
Jun 2020 | - | -$1.75M(-19.5%) | -$6.78M(-111.0%) |
Mar 2020 | - | -$2.18M(+91.3%) | $61.73M(-1.8%) |
Dec 2019 | $62.86M(-803.6%) | -$1.14M(-33.3%) | $62.86M(-1.3%) |
Sep 2019 | - | -$1.71M(-102.6%) | $63.71M(-2.3%) |
Jun 2019 | - | $66.75M(-6493.5%) | $65.19M(-3555.0%) |
Mar 2019 | - | -$1.04M(+266.3%) | -$1.89M(-78.9%) |
Dec 2018 | -$8.93M(-85.2%) | -$285.00K(+27.2%) | -$8.93M(-73.1%) |
Sep 2018 | - | -$224.00K(-32.9%) | -$33.23M(-45.1%) |
Jun 2018 | - | -$334.00K(-95.9%) | -$60.58M(+9.5%) |
Mar 2018 | - | -$8.09M(-67.1%) | -$55.34M(-8.4%) |
Dec 2017 | -$60.39M(+640.9%) | -$24.59M(-10.8%) | -$60.39M(+72.0%) |
Sep 2017 | - | -$27.57M(-662.0%) | -$35.10M(+148.8%) |
Jun 2017 | - | $4.91M(-137.3%) | -$14.11M(-22.4%) |
Mar 2017 | - | -$13.14M(-1982.2%) | -$18.18M(+123.1%) |
Dec 2016 | -$8.15M(-77.5%) | $698.00K(-110.6%) | -$8.15M(-70.2%) |
Sep 2016 | - | -$6.58M(-889.4%) | -$27.38M(+11.6%) |
Jun 2016 | - | $833.00K(-126.8%) | -$24.54M(-13.2%) |
Mar 2016 | - | -$3.11M(-83.2%) | -$28.28M(-21.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2015 | -$36.23M(+1588.0%) | -$18.54M(+396.8%) | -$36.23M(+115.6%) |
Sep 2015 | - | -$3.73M(+28.2%) | -$16.80M(+27.9%) |
Jun 2015 | - | -$2.91M(-73.7%) | -$13.14M(-8.6%) |
Mar 2015 | - | -$11.05M(-1342.7%) | -$14.38M(+570.1%) |
Dec 2014 | -$2.15M(-105.3%) | $889.00K(-1407.4%) | -$2.15M(-106.2%) |
Sep 2014 | - | -$68.00K(-98.4%) | $34.63M(-3.7%) |
Jun 2014 | - | -$4.15M(-450.0%) | $35.98M(-11.6%) |
Mar 2014 | - | $1.19M(-96.8%) | $40.68M(+0.1%) |
Dec 2013 | $40.63M(+514.7%) | $37.67M(+2846.0%) | $40.63M(+1167.9%) |
Sep 2013 | - | $1.28M(+134.2%) | $3.20M(-59.5%) |
Jun 2013 | - | $545.90K(-52.2%) | $7.92M(+5.5%) |
Mar 2013 | - | $1.14M(+379.8%) | $7.51M(+13.6%) |
Dec 2012 | $6.61M(-34.8%) | $238.10K(-96.0%) | $6.61M(-41.6%) |
Sep 2012 | - | $5.99M(+4306.0%) | $11.32M(+98.1%) |
Jun 2012 | - | $136.00K(-44.2%) | $5.72M(-32.6%) |
Mar 2012 | - | $243.70K(-95.1%) | $8.48M(-16.3%) |
Dec 2011 | $10.14M(+44.9%) | $4.95M(+1179.1%) | $10.14M(+25.3%) |
Sep 2011 | - | $386.90K(-86.7%) | $8.09M(+5.0%) |
Jun 2011 | - | $2.90M(+53.1%) | $7.70M(-3.8%) |
Mar 2011 | - | $1.90M(-34.6%) | $8.01M(+14.4%) |
Dec 2010 | $7.00M(-12.0%) | $2.90M(>+9900.0%) | $7.00M(+70.8%) |
Sep 2010 | - | $0.00(-100.0%) | $4.10M(-6.7%) |
Jun 2010 | - | $3.21M(+261.8%) | $4.39M(-3.0%) |
Mar 2010 | - | $886.90K(+200.6%) | $4.53M(-6.9%) |
Dec 2009 | $7.95M(+261.9%) | - | - |
Sep 2009 | - | $295.00K(-91.2%) | $4.86M(-12.3%) |
Jun 2009 | - | $3.34M(+537.0%) | $5.54M(+152.2%) |
Mar 2009 | - | $525.00K(-24.7%) | $2.20M(+31.4%) |
Mar 2009 | $2.20M(-42.7%) | - | - |
Dec 2008 | - | $697.50K(-28.5%) | $1.67M(+71.3%) |
Sep 2008 | - | $975.00K(>+9900.0%) | $976.50K(>+9900.0%) |
Jun 2008 | - | $0.00(-100.0%) | $2500.00(-85.7%) |
Mar 2008 | $3.84M(>+9900.0%) | - | - |
Dec 2007 | $17.50K(-41.7%) | $1500.00(+50.0%) | $17.50K(+9.4%) |
Sep 2007 | - | $1000.00(-93.3%) | $16.00K(+6.7%) |
Jun 2007 | - | $15.00K(>+9900.0%) | $15.00K(>+9900.0%) |
Mar 2007 | - | $0.00 | $0.00 |
Dec 2006 | $30.00K | - | - |
FAQ
- What is MiMedx Group, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for MiMedx Group, Inc.?
- What is MiMedx Group, Inc. annual CFF year-on-year change?
- What is MiMedx Group, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for MiMedx Group, Inc.?
- What is MiMedx Group, Inc. quarterly CFF year-on-year change?
- What is MiMedx Group, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for MiMedx Group, Inc.?
- What is MiMedx Group, Inc. TTM CFF year-on-year change?
What is MiMedx Group, Inc. annual cash flow from financing activities?
The current annual CFF of MDXG is -$34.20M
What is the all time high annual CFF for MiMedx Group, Inc.?
MiMedx Group, Inc. all-time high annual cash flow from financing activities is $62.86M
What is MiMedx Group, Inc. annual CFF year-on-year change?
Over the past year, MDXG annual cash flow from financing activities has changed by -$25.63M (-299.05%)
What is MiMedx Group, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of MDXG is -$2.88M
What is the all time high quarterly CFF for MiMedx Group, Inc.?
MiMedx Group, Inc. all-time high quarterly cash flow from financing activities is $66.75M
What is MiMedx Group, Inc. quarterly CFF year-on-year change?
Over the past year, MDXG quarterly cash flow from financing activities has changed by +$30.59M (+91.40%)
What is MiMedx Group, Inc. TTM cash flow from financing activities?
The current TTM CFF of MDXG is -$3.61M
What is the all time high TTM CFF for MiMedx Group, Inc.?
MiMedx Group, Inc. all-time high TTM cash flow from financing activities is $65.19M
What is MiMedx Group, Inc. TTM CFF year-on-year change?
Over the past year, MDXG TTM cash flow from financing activities has changed by +$38.42M (+91.41%)